Frontiers in Medicine (Aug 2023)
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin’s B lymphoma: a single center prospective clinico-pathological study
Abstract
BackgroundThe pathogenesis of eosinophilic dermatosis of hematologic malignancy (EDHM) is poorly understood. Previously thought to be a hypersensitivity reaction to insect bites, immune dysregulation and cytokine imbalance are now thought to be responsible. Its prognostic significance is unclear.ObjectiveTo describe the clinical, pathological and immunological findings in a series of oncohematological patients with EDHM.MethodsAn observational prospective cohort study of oncohematological patients receiving a diagnosis of EDHM between April 2017 and December 2018.ResultsA total of 15 patients with EDHM (10 females and 5 males) were identified among 422 oncohematological patients. Disease presentation varied from firm erythematous papules to more polymorphic presentations. The lesions were most prevalent on the exposed sites, 8/15 patients recalled an insect bite. Lesion seasonality was reported in 13/15 patients. IgE levels were elevated in six patients, circulating IL-4 and IL-5 were within a normal range. Twelve out of 15 patients developed skin manifestations after chemotherapy. The infiltrate could be eosinophil-rich or lymphocytic-rich. Interestingly, the histopathologic findings were in accordance with arthropod bites.ConclusionA role for insect bites in EDHM is supported by our findings. EDHM may be related to aggressive hematologic disease.
Keywords
